Methods and systems for controlling and/or increasing iontophoretic flux

• US 20040167459A1
• Filed: 02/21/2003
• Published: 08/26/2004
• Est. Priority Date: 02/21/2003
• Status: Abandoned Application

• Current Assignee: Aciont, Inc.
• Original Assignee: Aciont, Inc.
• Inventors: Higuchi, William I., Li, S. Kevin, Miller, David J.
• Application Number:
  US10/371,148
• Publication Number:
  US 20040167459A1
• Time in Patent Office: Days
• US Class Current: 604/20
• CPC Class Codes: A61N 1/0428 Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
• CPC Class Codes: A61N 1/0436 Material of the electrode
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61N 1/327 for enhancing the absorption properties of tissue, e.g. by electroporation

Abstract

An iontophoretic method is provided to selectively transport a compound of interest through a localized region of an individual'"'"'s body tissue that exhibits a low electrical resistance and/or a high permeability. The method involves placing a permselective material, typically having a resistance comparable or higher than the resistance of the localized region, in ion-conducting relation to the localized region. An electrical current is then applied through the permselective material to the localized region, thereby transporting the compound of interest iontophoretically through the localized region. When the permselective material is capable of hindering iontophoretic transport of a competing ion, the transference efficiency of the compound of interest is increased during iontophoresis. As a result, the compound of interest is delivered into or extracted from the localized region at an enhanced rate. As transport efficiencies approach unity, absolute predictivity of transport also becomes possible. Also provided are electrode assemblies and iontophoretic systems capable of carrying out the iontophoretic method.

Claims

1. An iontophoretic method for selectively transporting a compound of interest through a localized region of an individual'"'"'s body tissue, wherein the localized region exhibits an electrical resistance less than 100 kΩ

-cm² the method comprising;

(a) placing a permselective material in ion-conducting relation to the localized region, wherein the permselective material is capable of hindering iontophoretic transport of a competing ion that reduces transference efficiency of the compound of interest; and

(b) applying an electrical current through the permselective material to the localized region, thereby transporting the compound of interest iontophoretically through the localized region while hindering iontophoretic transport of the competing ion.

2. The method of claim 1, wherein the permselective material has an electrical resistance greater than the electrical resistance of the localized region.

3. The method of claim 1, wherein the localized region exhibits an electrical resistance no greater than about 10% of the electrical resistance of unpermeabilized skin tissue.

4. The method of claim 3, wherein the localized region exhibits an electrical resistance no greater than about 1% of the electrical resistance of unpermeabilized skin tissue.

5. The method of claim 1, wherein the individual is a mammal.

6. The method of claim 5, wherein the individual is human.

7. The method of claim 1, wherein the body tissue is mucosal tissue.

8. The method of claim 7, wherein the mucosal tissue is oral tissue.

9. The method of claim 8, wherein the oral tissue is buccal tissue.

10. The method of claim 1, wherein the body tissue is ocular tissue.

11. The method of claim 10, wherein the ocular tissue is scleral tissue.

12. The method of claim 10, wherein the ocular tissue is conjunctival tissue.

13. The method of claim 1, wherein the localized region is permeabilized before step (b) so as to exhibit an electrical resistance that corresponds to a tissue permeability that exceeds the permeability of the individual'"'"'s unpermeabilized skin tissue.

14. The method of claim 13, wherein the electrical resistance of the localized region is less than 10 kΩ

-cm².

15. The method of claim 14, wherein the electrical resistance of the localized region is less than 5 kΩ

-cm².

16. The method of claim 15, wherein the electrical resistance of the localized region is less than 2 kΩ

-cm².

17. The method of claim 13, wherein permeabilization reduces the electrical resistance of the localized region by at least about 90%.

18. The method of claim 17, wherein permeabilization reduces the electrical resistance of the localized region by at least about 99%.

19. The method of claim 13, wherein the tissue is permeabilized through use of a chemical permeation enhancer, electroporation current, ultrasound, photons, a piercing member, and/or combinations thereof.

20. The method of claim 13, wherein the body tissue is permeabilized mucosal tissue.

21. The method of claim 13, wherein the body tissue is permeabilized skin tissue.

22. The method of claim 1, wherein the electrical resistance of the permselective material is at least two times the electrical resistance of the localized region.

23. The method of claim 22, wherein the electrical resistance of the permselective material is at least five times the electrical resistance of the localized region.

24. The method of claim 23, wherein the electrical resistance of the permselective material is at least ten times the electrical resistance of the localized region.

25. The method of claim 24, wherein the electrical resistance of the permselective material is at least 20 times the electrical resistance of the localized region.

26. The method of claim 1, wherein the permselective material is provided in the form of a membrane.

27. The method of claim 1, wherein the permselective material is capable of hindering iontophoretic transport of a competing counter-ion that possesses a charge opposite to the charge of the compound of interest when ionized.

28. The method of claim 27, wherein the competing ion is negatively charged.

29. The method of claim 27, wherein the competing ion is positively charged.

30. The method of claim 1, wherein the electrical current comprises an alternating current.

31. The method of claim 30, wherein the electrical current further comprises a superimposed direct current.

32. The method of claim 1, wherein the electrical current comprises a direct current.

33. The method of claim 1, wherein the compound of interest is delivered into the body tissue.

34. The method of claim 1, wherein the compound of interest is delivered through the body tissue.

35. The method of claim 1, wherein the compound of interest is extracted from the body tissue.

36. The method of claim 35, wherein the extracted compound is endogenous to the body tissue.

37. The method of claim 36, wherein the extracted compound is glucose.

38. The method of claim 36, wherein the extracted compound is phenylalanine.

39. The method of claim 1, wherein the compound of interest is a pharmacologically active agent.

40. An iontophoretic electrode assembly for selectively transporting a compound of interest through a localized region of an individual'"'"'s body tissue, wherein the localized region exhibits an electrical resistance that corresponds to a tissue permeability that exceeds the permeability of the individual'"'"'s unpermeabilized skin tissue, the electrode assembly comprising:

an electrode adapted for electrical connection to a current source; and

a permselective material in ion-conducting relation to the electrode and having a surface adapted for contact with the localized region,

wherein the permselective material has an electrical resistance greater than the electrical resistance of the localized region and is capable of hindering iontophoretic transport of a competing ion that reduces transference efficiency of the compound of interest when the material is in contact with the localized region.

41. The electrode assembly of claim 40, wherein the permselective material is a membrane.

42. The electrode assembly of claim 40, wherein the membrane has a surface sized and/or shaped for direct contact with the localized region.

43. The electrode assembly of claim 42, wherein the body tissue is buccal tissue.

44. The electrode assembly of claim 42, wherein the body tissue is skin tissue.

45. The electrode assembly of claim 42, wherein the body tissue is ocular tissue.

46. The electrode assembly of claim 45, wherein the ocular tissue is scleral tissue.

47. The electrode assembly of claim 45, wherein the ocular tissue is conjunctival tissue.

48. The electrode assembly of claim 40, wherein the membrane is capable of hindering iontophoretic transport of a competing counter-ion that possesses a charge opposite to the charge of the compound of interest when ionized.

49. The electrode assembly of claim 40, further comprising a reservoir for containing the compound of interest, wherein the reservoir is in electrical contact with the electrode and the permselective material.

50. The electrode assembly of claim 49, wherein the reservoir is interposed between the electrode and the permselective material.

51. The electrode assembly of claim 50, further comprising a means for isolating the reservoir so as to prevent a redox product from entering the reservoir.

52. The electrode assembly of claim 42, wherein the means for isolating the reservoir is comprised of an agent that precipitates, neutralizes, repels, and/or binds to the redox product so as to prevent the product from entering the reservoir.

53. The electrode assembly of claim 51, wherein the means for isolating the reservoir is comprised of an additional permselective material that selects for the charge of the compound of interest when ionized.

54. The electrode assembly of claim 53, wherein the additional permselective material is a membrane.

55. The electrode assembly of claim 50, wherein the compound of interest is contained within the reservoir.

56. The electrode assembly of claim 40, wherein the compound of interest is contained within the permselective material.

57. The electrode assembly of claim 40, wherein the compound of interest is a pharmacologically active agent.

58. The electrode assembly of claim 40, further comprising a means for permeabilizing the localized region such that the region exhibits an electrical resistance no greater than about 20% of the electrical resistance of unpermeabilized tissue.

59. The electrode assembly of claim 58, wherein the means for permeabilizing the localized region permeabilizes the localized region such that the region exhibits an electrical resistance no greater than about 20% of the electrical resistance of unpermeabilized mucosal tissue.

60. The electrode assembly of claim 58, wherein the means for permeabilizing the localized region permeabilizes the localized region such that the region exhibits an electrical resistance no greater than about 20% of the electrical resistance of unpermeabilized skin tissue.

61. The electrode assembly of claim 58, wherein the means for permeabilizing the localized region comprises a chemical permeation enhancer.

62. The electrode assembly of claim 61, wherein the means for permeablizing the localized region further comprises an applicator that applies the chemical permeation enhancer to the tissue prior to iontophoresis.

63. The electrode assembly of claim 61, wherein the chemical permeation enhancer is in ion-conducting relation to the permselective material.

64. The electrode assembly of claim 61, wherein the permeation enhancer is contained in the permselective material.

65. The electrode assembly of claim 58, wherein the means for permeabilizing the localized region comprises a permeabilizing current applicator spaced apart from the electrode.

66. The electrode assembly of claim 65, wherein the permselective material is interposed between the electrode and the permeabilizing current applicator.

67. An iontophoretic system for selectively transporting a compound of interest through a localized region of an individual'"'"'s body tissue, comprising:

a permselective material capable of selectively hindering iontophoretic transport of a competing ion when the material is in contact with the localized region, wherein transport of the competing ion reduces transference efficiency of the compound of interest;

a first electrode adapted to be placed in ion-conducting relation through the permselective material to the localized region to allow iontophoretic transport of the compound therethrough;

a second electrode adapted to contact the individual'"'"'s body and spaced apart from the first electrode; and

a current source electrically connected to the first and second electrodes, for applying an electrical current to the localized region of body tissue to transport the compound of interest iontophoretically through the localized region; and

a means for permeabilizing the localized region such that the permselective material has an electrical resistance greater than the electrical resistance of the localized region after permeabilization by the means for permeabilizing the localized region.

68. The system of claim 67, wherein the second electrode is spaced sufficiently far apart from the first electrode such that the electrodes cannot simultaneously contact the body tissue of the localized region.

69. The system of claim 68, wherein the first electrode is adapted to contact ocular tissue.

70. The system of claim 69, further comprising a third electrode adapted to contact the individual'"'"'s body and spaced apart from the first and second electrodes, and a means for determining the voltage between the third electrode and at least one of the first and second electrodes.

71. An iontophoretic system for selectively transporting a compound of interest through a localized region of an individual'"'"'s body tissue, comprising:

a permselective material capable of hindering iontophoretic transport of a competing ion when the material is in contact with the localized region, wherein transport of the competing ion reduces transference efficiency of the compound of interest;

a first electrode adapted to be placed in ion-conducting relation through the permselective material with the localized region to allow iontophoretic transport of the compound therethrough;

a second electrode adapted to contact the individual'"'"'s body tissue and spaced apart from the first electrode; and

an alternating current source electrically connected to the first and second electrodes, for applying an alternating current to the localized region to transport the compound of interest iontophoretically through the localized region.

72. The system of claim 71, wherein the alternating current source applies sufficient current to lower the electrical resistance of the localized region to a level less than the electrical resistance of the permselective material.

73. The system of claim 72, wherein the first electrode is a perforated electrode.

74. The system of claim 73, further comprising a reservoir containing the compound of interest, wherein the first electrode is interposed between the reservoir and the permselective material.

75. The system of claim 71, further comprising a third electrode adapted to be placed between the permselective membrane and the localized region.

76. The system of claim 71, further comprising a direct current source.

77. The system of claim 76, wherein the direct current source is connected to at least one of the first and second electrodes.

78. The system of claim 71, where the permselective material comprises a polyelectrolyte capable of transferring an electrical current interdispersed in an insulating material.